STAR Protocols (Jun 2022)
Analyzing single cell transcriptome data from severe COVID-19 patients
- Nasna Nassir,
- Richa Tambi,
- Asma Bankapur,
- Noushad Karuvantevida,
- Hamdah Hassan Khansaheb,
- Binte Zehra,
- Ghausia Begum,
- Reem Abdel Hameid,
- Awab Ahmed,
- Zulfa Deesi,
- Abdulmajeed Alkhajeh,
- K.M.Furkan Uddin,
- Hosneara Akter,
- Seyed Ali Safizadeh Shabestari,
- Mellissa Gaudet,
- Mahmood Yaseen Hachim,
- Alawi Alsheikh-Ali,
- Bakhrom K. Berdiev,
- Saba Al Heialy,
- Mohammed Uddin
Affiliations
- Nasna Nassir
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE; Department of Biotechnology, Bharathidsasan University, Tiruchirappalli 620024, Tamilnadu, India
- Richa Tambi
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE; Department of Biotechnology, Bharathidsasan University, Tiruchirappalli 620024, Tamilnadu, India
- Asma Bankapur
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Noushad Karuvantevida
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE; Department of Biotechnology, Bharathidsasan University, Tiruchirappalli 620024, Tamilnadu, India
- Hamdah Hassan Khansaheb
- Dubai Health Authority, Microbiology and Infection Control Unit, Pathology and Genetics Department, Latifa Women and Children Hospital, Dubai, UAE
- Binte Zehra
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Ghausia Begum
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Reem Abdel Hameid
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Awab Ahmed
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Zulfa Deesi
- Dubai Health Authority, Microbiology and Infection Control Unit, Pathology and Genetics Department, Latifa Women and Children Hospital, Dubai, UAE
- Abdulmajeed Alkhajeh
- Medical Education & Research Department, Dubai Health Authority, Dubai, UAE
- K.M.Furkan Uddin
- Genetics and Genomic Medicine Centre, NeuroGen Children’s Healthcare, Dhaka, Bangladesh
- Hosneara Akter
- Genetics and Genomic Medicine Centre, NeuroGen Children’s Healthcare, Dhaka, Bangladesh
- Seyed Ali Safizadeh Shabestari
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Mellissa Gaudet
- Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada
- Mahmood Yaseen Hachim
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Alawi Alsheikh-Ali
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE; Dubai Health Authority, Dubai, UAE
- Bakhrom K. Berdiev
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
- Saba Al Heialy
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE; Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, QC, Canada
- Mohammed Uddin
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE; Cellular Intelligence (Ci) Lab, GenomeArc Inc., Toronto, ON, Canada; Corresponding author
- Journal volume & issue
-
Vol. 3,
no. 2
p. 101379
Abstract
Summary: We describe the protocol for identifying COVID-19 severity specific cell types and their regulatory marker genes using single-cell transcriptomics data. We construct COVID-19 comorbid disease-associated gene list using multiple databases and literature resources. Next, we identify specific cell type where comorbid genes are upregulated. We further characterize the identified cell type using gene enrichment analysis. We detect upregulation of marker gene restricted to severe COVID-19 cell type and validate our findings using in silico, in vivo, and in vitro cellular models.For complete details on the use and execution of this protocol, please refer to Nassir et al. (2021b).